Clinical Trial Update: Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing standard intensive chemotherapy with CPX-351 versus standard therapy alone in adults with newly diagnosed acute myeloid leukemia with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CPX-351 (liposomal daunorubicin/cytarabine)

Snippet

Sponsor: University of Ulm | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: ACTIVE_NOT_RECRUITING